INCB028050
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB028050, covering 2018-09-04 to 2018-09-04. Get the full timeline:
Most recent: Clinical Trial Update: INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic Drugs [Phase 2]